Chad Wotkowicz, MD
Urology · Brunswick, MENPI 1003884578
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $751 of the $1,024 with a category attached, or 73.3%. 7 manufacturers reported payments, led by Boston Scientific at 48.6% of the total. Reporting peaked in 2024 at $404 and has fallen 72.1% since, to $113 in 2025. That places this record below the midpoint for urology clinicians in ME, where the typical reported total is $1,024.
Across 22 payments — averaging $46.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$498
- Coloplast$255
- Procept Biorobotics Corporation$113
- Johnson & Johnson$65
- Rochester Medical Corporation$49
- C. R. Bard, Inc. & Subsidiaries$25
- plus $19 from 1 others
What the payments were for
- Travel & lodging$18918%
- Food & beverage$75173%
- Education$848%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 4 | $498 |
| Coloplast | 12 | $255 |
| Procept Biorobotics Corporation | 1 | $113 |
| Johnson & Johnson | 1 | $65 |
| Rochester Medical Corporation | 2 | $49 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,024 in reported general payments places this provider in the 50th percentile of 59 urology providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 30 | $20,319 |
| Tamsulosin Hcl | 342 | $5,353 |
| Finasteride | 181 | $2,234 |
| Oxybutynin Chloride ErOxybutynin Chloride | 99 | $2,129 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 17 | $813 |
| NitrofurantoinNitrofurantoin Macrocrystal | 15 | $801 |
| Oxybutynin Chloride | 111 | $726 |
| Testosterone Cypionate | 21 | $573 |
| Ciprofloxacin Hcl | 109 | $554 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 15 | $330 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 15 | $270 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $260 |
| Bicalutamide | 11 | $236 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 24 | $134 |
| Cephalexin | 19 | $114 |
Paid to pharmacies, not to this prescriber.
Other urology in Brunswick
- Michael CurtisBrunswick$2K
- Richard HartnettBrunswick$978
- Griffith BatstoneFarmington$123K
- David SobelPortland$58K
- Marc HodroffPortland$17K
- Evan DunnLewiston$9K
- Robert FisherRockport$9K
- Christopher HenryLewiston$6K
- Jesse SammonSouth Portland$6K
- Sanchita BoseSouth Portland$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.